Ulta Beauty, Inc. (NASDAQ: ULTA) — The Category Killer at Its Cheapest in a Decade, After the Crowd Mistook a Normalizing Margin for a Broken Moat

Date: June 20, 2026 Note: An independent fundamental research note. The analysis below carries no recommendation and no price target — a directional view appears only in the labeled Author’s Take block.

⚡ Author’s Take

This block is the author’s own independent opinion and general information only — not investment advice. The analysis that follows takes no position and names no price target.

Verdict: HOLD / accumulate-on-weakness in the ~$400–460 zone (≈15–17x the ~$28 FY2026 EPS guide, ≈12x EV/EBITDA, ≈8% FCF yield). Not a short. Own-the-quality at today’s multiple; size up below ~$420. Fair value ~$520–620. Conviction: medium.

The market is doing something it does to ULTA roughly once a cycle: extrapolating a deceleration off a sugar-high into the death of the franchise. Operating margin has fallen from a 16.2% post-COVID peak (FY ended Jan-2023) to 12.5% (FY ended Jan-2026), and the stock has obediently round-tripped a violent momentum move — $314 (Mar-2025) → $707 ATH (Feb-2026) → $456 — leaving it at its cheapest valuation in a decade (AZI composite 10.8th own-history percentile; ~17.8x trailing P/E for a business that still earns a 24% ROIC, throws off ~$1.5B of clean free cash flow on a net-cash balance sheet, and is still growing — comps +5.3% in the most recent quarter, sales +11%). That is the entire tension: a genuinely elite specialty retailer is being priced as a structurally impaired one because its margin is normalizing toward a still-excellent ~12.5% and competition (Sephora-at-Kohl’s, Amazon, brand DTC) is real but, on the evidence, not yet winning — ULTA gained prestige share again last quarter. The thing the bears are right about — peak margins are not coming back — is already in the price three times over; the thing they are wrong about — that the moat (scale + the ~47-million-member loyalty data engine + the “all things beauty, all in one place” mass-prestige format) is eroding — is contradicted by the share data.

What keeps this a HOLD rather than a table-pounding BUY: the deceleration is genuine (full-year comp guide of just +2.5–3.5% vs. a +5.3% Q1 implies a soft back half), the easy margin gains are behind it, Space NK / international is a lower-return, integration-risk diversification of a perfect domestic model, and the LTIP was quietly stripped of all performance metrics (no ROIC, no relative-TSR governor) — a real, if not yet costly, governance demerit. Framing: deep-value-in-quality / abandoned compounder — explicitly not a momentum name (factor momentum is mildly negative, the tape is a 6-month falling knife down 35% off the high) and not a falling-knife-into-impairment (net cash, 24% ROIC, growing). The single fact that flips me bullish: two more quarters of positive comps with operating margin holding flat-to-up — proof the 12.5% is the floor, not a way-station. The single fact that flips me bearish: comps rolling negative while Sephora/Amazon take measurable prestige share — i.e., the bear’s “format is being disrupted” thesis showing up in the share data for the first time. Tag: “they marked down the whole castle because the moat stopped getting deeper.”

📈 Stock Price Action — Five-Year Event Map

Factual price history. The price moves are FACT; the attributed drivers are INTERPRETATION. No recommendation, no target.

Over five years ULTA has been a wide, choppy round-trip with one spectacular spike at the end: roughly $280 (early 2021) → a $276 trough (May-2022) → repeated runs at $550–570 that failed (2023–24) → a $314 cycle low (Mar-2025) → a parabolic recovery to a $706.82 all-time high (Feb-17-2026) → a 35% collapse back to ~$456 today, sitting essentially at its 52-week low ($450.75, Jun-17-2026) and below its 21-, 50- and 200-day moving averages ($482 / $509 / $539). Five-year price return is roughly +60% (CAGR ~10%), but almost all of it is the 2025 recovery; the stock was dead money for the three years to early 2025. Beta is a low ~0.85 and the name is highly idiosyncratic (factor R² ~0.26), so these are largely company-specific moves.

Cycle narrative. Events 1–2 are the COVID/post-COVID beauty boom that drove margins to a ~16% peak the company itself now calls unsustainable. Events 3–5 are the first growth scare — management’s own Spring-2024 admission of “softening” demand and intensifying competition, compounded by a CEO change, took the stock to a $314 low and a sub-13x multiple. Event 6 is the redemption arc: new CEO Kecia Steelman’s execution re-accelerated comps and the stock more than doubled into a Feb-2026 all-time high — a genuine momentum melt-up. Events 7–8 are the unwind: nothing in the actual results broke (Q4 beat, Q1 beat, comps positive, share gains continuing), but a stock that had priced flawless compounding could not survive a guide that honestly flagged decelerating comps and Space-NK margin absorption — so it has fallen 35% and now trades cheaper than at almost any point in its public life. Each number is traceable to primary sources (price history; ULTA 8-K/earnings prints; transcripts).

1. Executive Summary

Ulta Beauty is the largest dedicated beauty retailer in the United States — 1,591 stores (1,505 domestic), ~$12.4 billion in fiscal-2025 (year ended Jan-31-2026) sales, ~47 million loyalty members, and a category-defining “all things beauty, all in one place” format that puts mass and prestige cosmetics, skincare, fragrance, haircare and in-store salon services under one roof. It is, by the financial evidence, one of the best retailers in America: a 24% return on invested capital, a 39% gross margin, ~$1.5 billion of free cash flow at a 1.3x cash-conversion of net income, no funded debt (its ~$2.1B of balance-sheet “debt” is entirely capitalized operating leases; it is net-cash), and a decade of relentless buybacks that have retired ~22% of the shares (56.6M → 44.2M).

The investment debate is not about quality — it is about whether the last three years of margin decline is normalization or deterioration. Operating margin fell from a COVID-era peak of 16.2% (FY ended Jan-2023) to 12.5% (FY ended Jan-2026) as the post-pandemic makeup surge faded, promotions and labor reinflated, and competition intensified (Sephora’s rollout inside Kohl’s, Amazon’s premium-beauty push, and brands selling direct). The bear reads this as a structurally challenged format losing its moat. The evidence reads otherwise: revenue is still compounding (+9.7% last year, +11% last quarter), the company gained prestige market share again in Q1 fiscal-2026, comparable sales rose 5.3%, and management guides operating margin to stabilize (flat to +20bps) in fiscal-2026 on ~$13.1–13.2B of sales and $28.05–28.55 of EPS (~+9–11%).

Crucially, the valuation has already priced the bear case. After a violent round-trip from a $314 low (Mar-2025) to a $707 all-time high (Feb-2026) and back to $456, ULTA trades at ~17.8x trailing / ~16x forward earnings, ~12x EV/EBITDA, ~8% free-cash-flow yield, and an AZI own-history valuation percentile of 10.8 — cheaper than it has been at virtually any point in the past decade, the COVID crash included. The market is paying a low-teens multiple for a 24%-ROIC, net-cash, share-shrinking cash machine that is still growing. The risk is not balance-sheet or franchise risk; it is multiple-and-deceleration risk — that comps fade and the margin floor proves lower than 12.5%. This note lays out the moat, the normalization, the competitive threats, the capital allocation (strong on returns, weak on incentive design), and the embedded expectations that make ULTA, at this price, an abandoned-quality situation rather than a value trap.

2. Business Overview

What it is. Ulta Beauty operates the largest specialty-beauty retail platform in the U.S., built on a deliberately unsegmented assortment: a single store carries ~25,000 products from ~600+ brands spanning the entire price and prestige spectrum — drugstore mass brands (Maybelline, NYX, e.l.f.), masstige (The Ordinary, CeraVe), prestige (Lancôme, Estée Lauder, MAC, Clinique), exclusive/“Only at Ulta” brands (ColourPop, PATTERN, exclusive fragrance lines like NOYZ), and a private-label Ulta Beauty Collection. This “mass-meets-prestige under one roof” model is ULTA’s defining structural choice and the source of its differentiation versus Sephora (prestige-only) and the drugstore/mass channel (mass-only).

How it makes money. Three intertwined engines:

1. Merchandise retail (~96% of sales) — product sold across stores and e-commerce. Category mix (FY ended Jan-2026): Cosmetics 38%, Skincare & wellness 24%, Haircare 19%, Fragrance 13%, Services 4%, Other 2%. The mix is shifting in a telling way: cosmetics has fallen from 41% (FY2024) to 38% as the post-COVID makeup boom matures, while skincare/wellness (22%→24%) and fragrance (11%→13%) rise — a healthier, less faddish revenue base than a makeup-heavy mix.
2. Salon services (~4% of sales) — hair, skin, brow, makeup and nail services in ~full-service salons inside most stores. Low-margin on its own but a powerful traffic and loyalty driver; ULTA is one of the largest salon operators in the country.
3. The loyalty and data flywheel — the Ulta Beauty Rewards program (~47 million active members, +4% YoY) captures the overwhelming majority of sales, generating first-party purchase data that powers personalization, targeted promotion, vendor co-op marketing, and a nascent retail-media business. This is not a separate revenue line so much as the connective tissue that makes the merchandise engine more productive than a standalone retailer’s.

Footprint and channels. 1,591 stores as of Jan-31-2026 (1,505 U.S. company-operated + 86 international company-operated, the latter overwhelmingly the recently-acquired Space NK luxury-beauty chain in the U.K./Ireland, 84+2). Omnichannel is mature: buy-online-pickup-in-store, ship-from-store, same-day delivery (now via Uber Eats), and buy-now-pay-later (Klarna). Newer surfaces include a UB Marketplace third-party platform and a TikTok Shop launched in Q1 fiscal-2026. International is early-stage and asset-light outside Space NK: a Mexico joint venture with Grupo Axo (first stores Aug-2025) and a Middle East franchise with Alshaya (first store Kuwait, Nov-2025; UAE/Saudi planned 2026).

Recurring vs. non-recurring. Beauty consumables (skincare, haircare, fragrance refills, cosmetics replenishment) are inherently repeat-purchase, and the loyalty program institutionalizes that repeat behavior — effective “recurring” revenue without contracts. The salon and services side adds appointment-based recurrence. This is a consumer-staple-like demand profile (people replace mascara and shampoo in recessions) wrapped in a discretionary-retail multiple — part of why beauty proved so recession-resistant in 2022–23.

The economic engine, mechanically. ULTA’s profit is built from a high gross margin (~39%) generated by three reinforcing sources — favorable buying terms from scale, vendor co-operative marketing funding (brands pay ULTA to merchandise, sample, and promote them), and a growing mix of higher-margin private-label and exclusive brands — against which it carries the fixed costs of a national store fleet, distribution network, marketing, and the loyalty/technology platform. The model’s operating leverage is therefore comp-driven: incremental same-store sales fall to the bottom line at a high rate because the store and corporate cost base is largely fixed, which is why the post-COVID comp boom drove margins to 16% and why the subsequent comp deceleration (plus SG&A reinvestment) pulled them back to 12.5%. Understanding this mechanism is the key to the whole thesis: the margin is a function of comp momentum and SG&A discipline, not of a structurally eroding gross margin (which has been rock-stable). That distinction — operating-leverage cyclicality versus gross-margin erosion — is exactly what separates the “normalization” reading from the “deterioration” reading, and the gross-margin stability decisively favors the former.

Verdict: A genuinely differentiated, scaled, cash-generative retail platform with a demand profile closer to consumer staples than to discretionary retail. The format is the franchise; the loyalty data is the compounding asset.

3. Industry Dynamics

Market structure. The U.S. beauty market (cosmetics, skincare, fragrance, haircare, plus services) is a large (~$100B+), structurally growing category that has consistently outpaced general retail, supported by (a) demographic tailwinds (Gen-Z/Gen-Alpha entering the category younger, skinification and wellness crossover, men’s grooming), (b) premiumization (the durable mix-shift from mass to prestige), and © the category’s striking resilience — the “lipstick effect,” where consumers trade down on big-ticket discretionary items but maintain small affordable indulgences. Management reiterated on the Q1 fiscal-2026 call that “growth in the beauty category remains healthy, even as consumers are increasingly value-focused.”

Profit pools and value chain. Beauty is a structurally attractive retail category for one core reason: brands need physical and digital distribution that offers discovery, education, trial, and assortment breadth, and most cannot economically replicate that themselves. A prestige brand can sell direct, but it cannot easily put its product in front of a beauty enthusiast browsing 600 other brands, nor provide the loyalty-driven cross-sell that a destination retailer does. That gives specialty beauty retailers genuine bargaining power and access to vendor co-op marketing dollars — a higher-margin structure than commodity general merchandise. Gross margins in the high-30s/low-40s (ULTA at 39%) reflect this; a grocery or general-merch retailer earns half that.

Competitive intensity — the crux. The bear case lives here, and it is not frivolous:

• Sephora (LVMH) — the prestige-beauty leader, which has aggressively expanded its U.S. doorcount via shop-in-shops inside Kohl’s (~900 locations), bringing prestige beauty to suburban/middle-America locations that were historically ULTA’s stronghold. This is the single most-cited competitive threat.
• Amazon — building a “Premium Beauty” store and luxury-beauty partnerships, attacking on convenience and price, particularly in replenishment skincare/haircare.
• Mass retail (Target, Walmart) — Target via its own “Ulta Beauty at Target” shop-in-shop (now ending, see ) and its prestige push; Walmart up-massing its beauty assortment.
• Brand DTC — prestige and indie brands selling direct via their own sites and social commerce (TikTok Shop), disintermediating the retailer.
• The mass channel and drugstores — for the cosmetics and mass-skincare portion.

The 10-K is candid: the markets are “highly competitive with few barriers to entry,” and ULTA competes against “a diverse group of retailers, both small and large.” This is a real structural feature: beauty retail has low barriers to entry at the individual-store level. The barrier is at the scale-and-data level, not the storefront level (see competitive position).

Regulation. Light-touch (product-safety, labeling, consumer-protection, salon-licensing). Not a meaningful structural factor versus, say, healthcare or financials.

Capital cycle (Marathon lens). Beauty retail has attracted capital — Sephora’s Kohl’s rollout and Amazon’s push are textbook “high returns attract competition.” But the supply response is doorcount/channel rather than a flood of new ULTA-style category killers, and the category’s organic demand growth has so far absorbed it. The Marathon warning sign would be margin pressure across the whole group as everyone discounts to defend share; the early evidence (ULTA still gaining prestige share, margin guided to stabilize) suggests rational, not destructive, competition — for now. This bears close watching.

Verdict: A structurally good category (growing, resilient, premiumizing, vendor-funded margins) experiencing a cyclically intensifying competitive moment. The industry is attractive; the competitive temperature is the live risk.

4. Competitive Position

The moat, named precisely. ULTA’s advantage is a scale-plus-captive-data economies-of-scale moat in Greenwald’s taxonomy — the genuine kind, where fixed costs (national store network, distribution centers, marketing, technology, the loyalty platform) and a proprietary data asset are spread over a sales base no competitor in its specific format can match. It is reinforced by a customer-captivity layer (habit + loyalty-program switching friction) that is real but, candidly, moderate rather than ironclad.

The moat shows up where Greenwald says it must — in the financial outcomes:

• ROIC of ~24% (FY ended Jan-2026), down from ~34% at the 2023 peak but still ~3–4x a cost of capital — a business earning these returns for 15+ years is not operating in a commodity market.
• 39% gross margin — vendor co-op dollars, private label, exclusive brands, and scale buying power that a sub-scale competitor cannot replicate.
• Market-share stability/gains — the Greenwald acid test. ULTA gained prestige-beauty share again in Q1 fiscal-2026 and was roughly flat in mass, despite the Sephora-at-Kohl’s and Amazon onslaught. A moat that holds or grows share under direct, well-capitalized attack is a real moat.

The four pillars of differentiation:

1. Format (“all things beauty, all in one place”). The unsegmented mass-to-prestige assortment is structurally hard to copy. Sephora is prestige-only (no mass, limited drugstore brands); the mass channel lacks prestige and services. ULTA is the only national player serving the whole basket and the whole demographic, which maximizes basket size, trip frequency, and the addressable customer.
2. Loyalty + first-party data (~47M members). This is the compounding asset. It captures the vast majority of transactions, enabling personalization, efficient promotion, vendor-funded marketing, and a retail-media flywheel. Replicating 47 million members of purchase history is a multi-year, multi-billion-dollar barrier.
3. Scale. 1,500+ U.S. stores, national distribution, and ~$12B of buying power confer cost and assortment advantages, plus the ability to win brand exclusives (“Only at Ulta”) that drive differentiated traffic.
4. Services + experience. In-store salons, brand activations (40,000+ in-store events in Q1), and beauty-enthusiast staffing create an experiential reason to visit a store that pure e-commerce cannot match and that deepens loyalty.

Where the moat is weaker than the bulls claim. Customer captivity in beauty is genuinely limited — a beauty enthusiast shops Sephora and Ulta and Amazon and brand DTC; loyalty is to brands and to deals, not exclusively to the retailer. Switching “cost” is mostly the mild friction of loyalty points and habit. So the moat is real on the cost/scale/data axis and modest on the captivity axis. The honest read: ULTA’s advantage is durable enough to hold share and 20%+ ROIC, but not so absolute that it can raise prices into a value-conscious consumer or ignore Sephora/Amazon. That is exactly why margins normalized — competition is a tax on the moat, not a breach of it.

Direct comparison. Against Sephora, ULTA wins on mass+services breadth, suburban doorcount, and loyalty scale; loses on pure prestige/luxury cachet and global footprint. Against Amazon, ULTA wins on discovery/curation/trial/services; loses on convenience and replenishment price. Against brand DTC, ULTA wins on cross-brand discovery and the inability of most brands to profitably run their own retail; loses incrementally as social commerce matures (which is why ULTA is leaning into TikTok Shop rather than ignoring it).

Greenwald cross-check. Run the formal test from Competition Demystified: a genuine moat requires (1) evidence of barriers to entry, (2) stable or rising market share, and (3) ROIC durably above cost of capital. ULTA passes all three. Barriers: a new entrant would need to build ~1,500 stores, a national DC network, a 47-million-member loyalty database, and ~600 brand relationships (including exclusives) to replicate the format — a multi-billion-dollar, multi-year undertaking that the unit economics of beauty retail do not obviously justify, which is precisely why no one has done it and why the threats come from adjacent scaled players (Sephora, Amazon) repurposing existing infrastructure rather than from de-novo entrants. Share: stable-to-rising over a decade and gaining in prestige even now. ROIC: 24%, ~3–4x WACC, for 15 years. The one place ULTA fails a stricter Greenwald reading is customer captivity — Greenwald’s strongest moats combine economies of scale with captive customers (high switching costs, habit, search costs), and beauty consumers are demonstrably not captive. So ULTA sits in the “economies of scale + weak captivity” quadrant: a real but contestable moat, which is exactly consistent with a business that holds share and 24% ROIC but cannot prevent margin normalization when well-capitalized rivals attack. The financial signature matches the structural diagnosis.

Verdict: A durable but not impregnable competitive advantage — a genuine economies-of-scale + data moat that has held share through a direct, well-funded competitive assault, validated by 20%+ ROIC, but resting on contestable (not captive) customer demand. Not a crowded-market also-ran; a real category leader being tested, not toppled.

5. Growth History and Forward Opportunities

History. ULTA compounded revenue from ~$6.2B (COVID-hit FY ended Jan-2021) to $12.4B (FY ended Jan-2026) — roughly doubling in five years, ~15% CAGR, almost entirely organic until the FY2026 Space NK acquisition. The trajectory by year (FY ending Jan): $6.15B → $8.63B → $10.21B → $11.21B → $11.30B → $12.39B. Two phases are visible: an explosive post-COVID rebound (FY2022–23, comps in the high teens/low 20s as makeup roared back), then a normalization (FY2024–25 comps decelerated to low-single-digits and a +0.7% trough in the year ended Jan-2025), then a re-acceleration under new management (FY ended Jan-2026 sales +9.7%; Q1 fiscal-2026 comps +5.3%).

The growth has been high quality: driven by comparable-sales (ticket + transactions), new-store productivity, e-commerce, and loyalty-member growth — not by financial engineering or serial acquisition. Q1 fiscal-2026’s +5.3% comp split — average ticket +3.7%, transactions +1.6% — shows both pricing/mix and traffic contributing, the healthiest kind of comp.

Forward opportunities, ranked by credibility:

1. Core U.S. comp + share gains (highest credibility). The bedrock. Management frames the core U.S. business as “fundamentally strong,” still gaining prestige share. Continued mid-single-digit comps + 50–60 net new stores/year is the base-case growth engine.
2. Exclusive/owned brands (“Only at Ulta,” multiple $100M+ brands over time). Higher-margin, differentiated, traffic-driving. NOYZ, ColourPop, PATTERN and others; an explicit ambition to build several $100M+ exclusive brands. This is the most attractive margin-accretive growth lever.
3. Retail media / UB Marketplace / services. Monetizing the 47M-member data asset via advertising and a third-party marketplace — high-incremental-margin revenue that leverages existing traffic. Early but strategically the most valuable optionality.
4. Digital/social commerce (TikTok Shop, Uber Eats same-day, Klarna). Meeting younger and convenience-driven consumers where they are; defends against DTC/Amazon disintermediation.
5. International (lowest credibility / lowest return). Space NK (UK), Mexico JV, Middle East franchise. This is real expansion of the addressable market but also a lower-return, higher-risk diversification away from a perfect domestic model — beauty retail does not travel as cleanly as the bulls hope, and Space NK is margin-dilutive in the near term. Treat as optionality, not a core return driver.

The honest constraint. ULTA is a ~$12B-revenue retailer with 1,500 domestic stores; the U.S. is approaching maturity (the door-growth runway is 50–60/year, not hundreds). Forward growth is comp-plus-mix-plus-media-plus-international, decelerating from the post-COVID pace by arithmetic necessity. The FY2026 guide of +6–7% sales / +2.5–3.5% comps is a mature-grower profile, not a hyper-growth one — and the market’s disappointment that Q1’s +5.3% won’t persist all year is exactly this maturity becoming visible.

Verdict: High-quality, decelerating growth. Organic, cash-funded, share-gaining — but unmistakably a mid-single-digit comp grower now, not the high-teens compounder of 2022. The margin-accretive levers (owned brands, retail media) are the bull’s reason to believe the next leg of value creation is per-share earnings, not just revenue.

6. Financial Quality

This is the section where ULTA shines, and where the “broken company” narrative falls apart on contact with the numbers.

Margins and their normalization. Gross margin is remarkably stable at ~39% across the cycle (31.7% in COVID FY2021, then 39.0%/39.6%/39.1%/38.8%/39.1%) — a sign of durable vendor economics and pricing discipline, not a business losing pricing power at the gross line. The compression is entirely at the operating line: operating margin ran 12.4% (FY2020) → 5.95% (COVID) → 15.1% → 16.2% peak (FY ended Jan-2023) → 15.0% → 14.0% → 12.5% (FY ended Jan-2026). The driver is SG&A deleverage — the 10-K attributes it to higher incentive comp, higher store payroll/benefits, higher corporate overhead from strategic investments, and reinflated store expenses, plus “deleverage of other revenue” (the lower-margin Target royalty winding down) and channel mix. In plain terms: the COVID years over-earned on a makeup boom with under-invested SG&A, and the last three years gave that excess back. A 12.5% operating margin is not distress — it is a very good specialty-retail margin (most apparel/general retailers earn 5–10%); it is simply not 16%. Management now guides margin to stabilize (flat to +20bps in fiscal-2026), which is the single most important number in the whole story: if true, the normalization is over.

Returns on capital — still elite. ROIC ~24% (FY ended Jan-2026), down from a ~34% peak but multiples of any reasonable WACC. ROE of 72% is buyback-inflated (shrinking equity) and should be discounted, but even ROA at ~18% confirms genuine asset productivity. A retailer earning 24% on invested capital for 15 years is, definitionally, advantaged.

Cash generation and quality of earnings — clean. Operating cash flow of ~$1.6B converts net income at 1.3x (FY ended Jan-2026 OCF/NI 1.30x — high quality, working-capital and D&A tailwinds exceed the modest SBC), funding ~$450M of capex and leaving ~$1.5B of free cash flow (FCF/share ~$33.5; ~8% FCF yield at today’s price). There is no accrual-driven earnings inflation here; net income is backed by cash, year after year. Stock-based compensation is immaterial (~$37M, <0.3% of revenue) — a genuine rarity that means GAAP EPS is real EPS, not an SBC mirage (contrast with the tech/semicap names where SBC is the entire “earnings” debate).

Balance sheet — fortress / net cash. This is the most under-appreciated fact. ULTA carries no funded debt. The ~$2.1B of “debt” on the balance sheet is entirely capitalized operating-lease liabilities — a retailer’s stores. Against $494M of cash + short-term investments, ULTA is net cash (ROIC computes net debt at negative $362M). There is zero refinancing risk, zero covenant risk, and the entire ~$1.5B annual FCF is discretionary. For a retailer, this is as strong as it gets.

Per-share dynamics. Diluted EPS: $17.98 (FY2022) → $24.01 → $26.03 → $25.34 → $25.64 (FY ended Jan-2026). Note the plateau at ~$25–26 across FY2023–2026: revenue grew but margin compression offset it, and EPS was held roughly flat with the buyback doing the heavy lifting on a per-share basis. This is the crux of the bear’s “earnings have stopped growing” point — and it is true for the normalization window. The bull’s rejoinder: with margin now stabilizing, FY2026 EPS is guided to $28.05–28.55 (+9–11%), i.e., the per-share engine restarts once the margin headwind ends.

Unit economics. New stores are productive and quick-to-profitability (pre-opening expense ~$15.8M for 50–60 stores/year), funded entirely from internal cash. Inventory is well-controlled (cash-conversion cycle ~71 days; the 10-K cites lower shrink as a margin tailwind — an operational positive in a sector plagued by theft).

Peer benchmarking. Against specialty/beauty-adjacent retail, ULTA’s financial profile is top-tier. Bath & Body Works (BBWI, the closest factor peer) earns higher operating margins (~18–20%) but on a single-brand, vertically-integrated model carrying meaningful funded debt and far less assortment breadth — a different (more brand-concentrated, more leveraged) risk profile. e.l.f. Beauty (a brand, not a retailer) grows faster but is a supplier into ULTA’s channel, not a comparable. Versus broadline and apparel retail (Target ~5% op margin, most apparel retailers 6–10%, off-price TJX ~10–11%), ULTA’s 12.5% operating margin and 24% ROIC are superior, and its net-cash balance sheet is rarer still — most retailers carry net debt and lower returns. The instructive comparison is to ULTA’s own history: this is a business that earned 12–16% operating margins through an entire cycle including a pandemic, never posting a loss except in the COVID-shuttered quarters, with returns on capital that would be the envy of nearly any retailer. The “broken retailer” framing the multiple implies is contradicted by where ULTA sits in the retail quality distribution — near the top.

One honest caution on the cash-flow optics. The reported FCF of ~$1.5B benefited modestly from working-capital timing (a large accounts-payable inflow in the latest year), so a normalized FCF run-rate closer to ~$1.3–1.4B is the more conservative anchor — still a ~7% FCF yield. And the buyback, while value-additive on average, is funded entirely from operating cash with no leverage employed; a more aggressive (debt-funded) capital structure could juice per-share returns further but would forfeit the fortress balance sheet — management’s conservatism here is a defensible choice, not a flaw.

Verdict: Yes, economics are excellent and improve with scale — 39% gross margin, 24% ROIC, 1.3x cash conversion, net cash, immaterial SBC, top-of-retail-distribution returns. The blemish is the multi-year operating-margin compression, which is normalization off a bubble peak rather than deterioration of the underlying model, and which management guides to be ending. On quality of earnings, ULTA is in the top decile of retail.

7. Capital Allocation

The scorecard: excellent on returns of capital, average on M&A, and a real demerit on incentive design.

Buybacks — disciplined and enormous. ULTA has no dividend; it returns essentially all free cash via repurchase. Buybacks over the last five fiscal years: ~$1,538M / $907M / $1,018M / $1,027M / $915M — cumulatively ~$5.4B, retiring the share count from 56.6M to 44.2M, a ~22% reduction. Critically, this has been value-additive on average: much of it executed in the $300s–$400s (e.g., the FY ended Jan-2025 repurchases around the $314–400 range), and management raised the fiscal-2026 buyback target from $1B to $1.5B during Q1 — i.e., leaning in harder as the stock fell to ~$456. Buying back ~5–7% of the company per year at ~16x earnings / 8% FCF yield is rational capital allocation. (The one caution: ULTA, like most retailers, also bought stock at $500+ in 2023–24, so the program is not perfectly counter-cyclical — but it is far better-timed than the average corporate buyback.)

M&A — a new and unproven chapter. For its entire public history ULTA was an organic compounder that did essentially no acquisitions. That changed in FY ended Jan-2026 with Space NK (~$387M cash for the U.K. luxury-beauty chain) plus the Mexico JV and Middle East franchise. This is a deliberate pivot to international/inorganic growth as the domestic runway matures. The strategic logic (extend a proven format, add prestige/luxury capability, diversify geographically) is defensible, but the return logic is unproven: Space NK is margin-dilutive near-term, international beauty retail has a mixed track record industry-wide, and it diversifies away from a domestic model earning 24% ROIC into geographies that will, at best, earn less. The goodwill/intangibles on the balance sheet jumped from ~$11M to ~$655M as a result — still small relative to the company, but the first real impairment risk ULTA has carried. Watch this closely: the bull thesis is “owned brands + retail media + buybacks”; international is the part most likely to destroy value if management over-reaches.

Reinvestment. Capex (~$450M/yr) funds 50–60 new stores, remodels, supply chain, and technology/loyalty platform — all internally funded, all in service of the core moat. R&D is not a line item (it’s a retailer), but the technology and loyalty investment is the analog and appears well-spent (e-commerce strength, personalization).

Incentive alignment — the genuine weak spot. Here the governance read turns critical. ULTA’s annual bonus is tied to a single metric, “Incentive EBT” (earnings before taxes) — a profit goal with no return-on-capital governor. More notably, the Compensation Committee discontinued performance-based share (PBS) awards entirely, moving the long-term incentive to time-based RSUs and stock options with three-year cliff vesting. Read plainly: the LTIP now has no performance metrics at all — no ROIC hurdle, no relative-TSR gate, no comp/margin target. The committee’s stated rationale (not wanting to set long-term goals it deemed unhelpful) is candid but unsatisfying: it means executives are rewarded for tenure and share-price rather than for returns on the capital they deploy — precisely the wrong incentive for a company embarking on its first acquisitive, lower-return international push. ULTA’s actual capital-allocation behavior has been good (the buyback, the discipline), and its 5-year TSR (+131%) is strong, so this has not yet cost shareholders — but it is a real demerit and removes the guardrail that would discourage empire-building. Fact: bonus = Incentive EBT; LTIP = time-based RSUs/options, no performance conditions. Interpretation: a governance soft spot that matters more now that M&A is on the table.

Insider behavior. A new CEO (Steelman, Jan-2025) and new CFO (DelOrefice, Oct-2025); the Form 4 corpus over the trailing period is dominated by routine grants/award activity (the June-2026 cluster is annual director equity grants) rather than discretionary open-market purchases — no standout conviction-buying signal, but also no alarming insider distribution. Neutral.

Verdict: Above-average capital allocator on the things that compound per-share value (massive, reasonably-timed buybacks; disciplined internally-funded reinvestment; net-cash balance sheet), with two yellow flags: an unproven and lower-return international M&A pivot, and an LTIP stripped of all performance metrics. Net: good steward of cash, weak design of incentives.

8. Changes and Headwinds — Last Two Years

Leadership transition (completed). Dave Kimbell (CEO since 2021) departed; Kecia Steelman, the long-time COO, became CEO in January 2025, and Chris DelOrefice joined as CFO in October 2025. The transition coincided with the $314 cycle low and the subsequent recovery — the “Ulta Beauty Unleashed” strategy is Steelman’s, and the 2025 execution (comp re-acceleration, share gains, margin stabilization) is the early scorecard on the new team. So far, positive.

The competitive escalation (ongoing headwind). The defining external change of the period is the maturation of Sephora-at-Kohl’s (~900 doors bringing prestige beauty to ULTA’s suburban turf) and Amazon’s premium-beauty build-out. This is the structural pressure behind the margin normalization and the bear thesis. Net effect to date: ULTA has held and gained prestige share, but the competition is a permanent tax on margins and a reason the 16% peak won’t return.

The Target partnership ending (modest headwind, mixed signal). On Aug-14-2025, Ulta and Target announced a mutual agreement not to renew the “Ulta Beauty at Target” shop-in-shop partnership (600+ locations) when it concludes in August 2026. This is the “lower royalty income from our partnership with Target” management flagged in Q1. Financially it’s a small, low-margin royalty stream going away (a minor headwind to “other revenue” and a slight margin mix positive as a low-margin line exits). Strategically it removes a channel that arguably trained ULTA’s own customers to shop elsewhere. Net: small negative to revenue optics, neutral-to-slightly-positive to margin and strategic clarity.

International expansion (strategic change). The Space NK acquisition (Jul-2025), Mexico JV (Aug-2025), and Middle East franchise (Nov-2025) mark ULTA’s first material move beyond the U.S. — the biggest strategic shift in the company’s history (see ). Strengthens the long-term addressable market; weakens near-term margins and introduces integration/return risk.

Margin normalization (the through-line). Operating margin’s slide from 16.2% to 12.5% over three years is the dominant financial change of the period, now guided to stabilize. Whether it has truly bottomed is the open question.

Category/mix shift. Cosmetics declining (41%→38%) as makeup normalizes; skincare/wellness and fragrance rising. A healthier, less-faddish base, but it reflects the cooling of the makeup super-cycle that drove the 2022–23 boom.

Capital-return escalation. Buyback target raised $1B→$1.5B in fiscal-2026 — management voting with the balance sheet that the stock is cheap.

Verdict: The changes are a net wash bordering on slightly positive for the thesis: a credible new management team executing, margin guided to stabilize, capital return increased, and a strategic clean-up (Target exit) — set against genuinely intensifying competition and an unproven international bet. Nothing here suggests franchise impairment; much of it suggests a maturing company managing a normalization competently.

9. Risk Analysis (Risk Matrix)

Overall risk character: The risks are cyclical and competitive, not existential or financial. There is no leverage risk, no liquidity risk, no accounting risk, and no plausible total-loss scenario. The two that matter are competitive share loss and the margin floor — and both are currently breaking ULTA’s way (gaining share, margin guided to stabilize). The asymmetry is favorable: the balance sheet eliminates the left tail.

10. Valuation Discussion (Embedded Expectations)

No price target, no recommendation. This section frames what the market is underwriting.

Where the multiple sits. At ~$456, ULTA trades at:

• ~17.8x trailing P/E (TTM EPS $25.56) and ~16x forward (FY2026 guide $28.05–28.55).
• ~12x EV/EBITDA (TTM EBITDA ~$1.85B; EV ~$22B at current price, net of cash).
• ~8% free-cash-flow yield (~$1.5B FCF on ~$20B market cap).
• ~1.66x sales and ~7.3x book.
• AZI own-history valuation percentile: 10.8 composite (P/E 16.6, P/B 8.4, P/S 7.5) — i.e., cheaper than ~89% of its own last-decade range, the COVID crash included.

For context, ULTA’s own 10-year history has it trading 18–25x earnings in “normal” times and 20x+ in boom years; the COVID-2021 P/E spiked to ~90x on collapsed earnings. A sub-18x trailing / sub-16x forward multiple for a 24%-ROIC, net-cash, growing, share-shrinking franchise is a trough valuation by ULTA’s own standards.

What the current price embeds (reverse logic). At ~16x forward EPS with ~8% FCF yield and ~5–7% of shares retired annually, the market is implicitly underwriting something like: mid-single-digit revenue growth fading toward low-single-digit, operating margin stuck at ~12.5% or drifting lower, and continued competitive share pressure — i.e., a low-growth, ex-growth retailer. Crudely: an 8% FCF yield + ~3% per-share accretion from buybacks already clears a low-double-digit owner’s return with zero multiple re-rating and only modest growth. The market is paying for “mature, competitively-pressured, no-re-rating” — not for “compounder.”

What the market is pricing correctly: that the 16% peak margin and high-teens comps of 2022–23 are gone for good; that competition is permanent; that growth is decelerating; that international is a lower-return diversification.

What it may be pricing incorrectly: that the franchise is deteriorating rather than normalizing. The share-gain data, the stable 39% gross margin, the margin-stabilization guide, and the restarting per-share earnings engine (EPS +9–11% guided for FY2026 after a three-year plateau) all argue the business has found its footing at a still-excellent level of profitability. If margin holds at ~12.5% and comps stay positive low-single-digit, the multiple is too low for the cash generation and balance sheet.

Peer-multiple context. ULTA’s ~16x forward P/E and ~12x EV/EBITDA sit below most specialty-retail and beauty comparables despite superior returns and balance sheet. Bath & Body Works trades at a similar low-teens earnings multiple but with funded leverage and brand concentration; beauty suppliers (e.l.f., the prestige houses) trade at far richer multiples (20–40x) on faster growth; off-price quality retailers (TJX, Ross) command ~25x and high-teens-to-20x respectively for slower-growth, lower-ROIC-than-ULTA models with no net cash. On a quality-adjusted basis — ROIC, balance sheet, FCF conversion, share-count reduction — ULTA screens as the cheapest high-quality name in the broad consumer-retail complex. The market is applying a “structurally challenged retailer” multiple to a business whose financial profile says “category-leading compounder.” That gap is the opportunity and the risk: it closes upward if the franchise proves durable, or the gap is “correct” only if one believes the moat is genuinely breaking — which the share data does not yet support.

Scenario framing (illustrative, 2–3 year, not targets):

• Bear (~30%): Competition bites, comps fade toward flat/negative, operating margin slips below 12% (toward ~11%), international disappoints/impairs. EPS stalls near $26–28; multiple stays ~14–15x. Outcome: low-single-digit annual loss to roughly flat — cushioned by the 8% FCF yield and ongoing buyback, so even the bear case is not a disaster from this price.
• Base (~50%): Margin stabilizes ~12.5% as guided, comps run low-single-digit, owned brands/retail media add mix, buyback retires 5–6%/yr. EPS compounds high-single to low-double-digit toward ~$31–34 over 2–3 years; multiple holds ~16–18x. Outcome: low-double-digit annual return (earnings growth + buyback + a modest re-rate).
• Bull (~20%): Margin re-expands modestly (owned brands + retail-media mix lift margin back toward 13–14%), comps surprise to the upside, international proves additive, and the multiple re-rates toward ULTA’s historical ~20x as the “broken franchise” fear evaporates. EPS toward ~$35+ on a 19–20x multiple. Outcome: 50%+ over 2–3 years.

The distribution is positively skewed from this price because the balance sheet and FCF yield truncate the downside while the re-rating optionality (a return to even a market-average multiple for a far-above-average business) powers the upside.

Verdict: ULTA is priced as a low-growth, competitively-impaired retailer. The embedded bar is low — stabilize margin, grow comps low-single-digit, keep buying back stock — and the business is currently clearing it. The valuation has already paid for the bear case; the bull case is unpriced optionality.

11. Variant Perception

Consensus view. ULTA is a high-quality retailer whose best days (16% margins, high-teens comps) are behind it; competition from Sephora-at-Kohl’s and Amazon is structurally compressing returns; growth is decelerating to mid-single-digit; the stock deserves a below-historical multiple as a “GARP-turned-value” mature retailer. Sell-side has trimmed price targets (e.g., TD Cowen to $600, still above the current ~$456) — constructive but de-rated. The factor read confirms an abandoned name: mildly negative momentum (factor loading −0.06), a 6-month return of −35% (a falling knife on the tape), and 3-year dead-money performance — this is not a crowded momentum trade and not a beloved compounder; it is an out-of-favor quality name that the trend-followers have left.

The strongest bull case. ULTA is the dominant, structurally-advantaged U.S. beauty platform — 24% ROIC, 39% gross margin, net cash, ~$1.5B FCF — trading at its cheapest multiple in a decade because the market confused normalization off a COVID sugar-high with secular decline. The disconfirming evidence for the bear is already visible: ULTA is gaining prestige share under the full force of the Sephora/Amazon assault, gross margin is rock-stable at 39%, and management guides operating margin to stop falling. With the per-share earnings engine restarting (EPS +9–11% guided after a three-year plateau) and ~5–7% of the company retired annually at an 8% FCF yield, an owner earns a low-double-digit return with no multiple re-rating at all — and gets the re-rating (back toward a 20x historical norm) for free if the “broken” narrative dies.

The strongest bear case. Beauty retail has low barriers to entry, and the moat is more modest than the bulls admit — customer captivity is weak, and a well-capitalized Sephora-at-Kohl’s plus Amazon plus brand-DTC plus TikTok-Shop social commerce will permanently pressure both share and margin. The 16%→12.5% margin slide is the beginning of a structural decline, not a normalization that has bottomed; the FY2026 comp guide of +2.5–3.5% (vs. +5.3% Q1) signals the deceleration is accelerating; the makeup category (38% of mix) is faddish and cooling; and management has just (a) embarked on its first acquisitive, lower-return international push at exactly the wrong moment and (b) stripped its LTIP of all return-on-capital discipline. A mature, ex-growth, competitively-besieged retailer deserves ~14x, not 18x — and earnings could disappoint the +9–11% guide if the consumer weakens.

The 3–5 assumptions that matter most:

1. Is 12.5% the operating-margin floor, or a way-station to ~10–11%? (The single most important variable. Bull: floor. Bear: way-station.)
2. Can ULTA keep gaining/holding prestige share against Sephora-at-Kohl’s and Amazon? (The moat’s acid test. So far: yes.)
3. Do comps stay positive (low-single-digit), or roll negative in a value-focused consumer? (Drives both revenue and margin leverage.)
4. Is international/owned-brands/retail-media accretive to per-share value, or a distraction/value-drag? (Determines whether growth quality holds as the U.S. matures.)
5. Does the multiple re-rate toward the historical norm, or stay de-rated? (The optionality; depends on 1–3 resolving bullishly.)

What would falsify each side:

• Falsifies the bull: two consecutive quarters of negative comps with operating margin breaking below 12%, and measurable prestige-share loss to Sephora/Amazon. That would confirm structural decline, not normalization.
• Falsifies the bear: two-plus quarters of positive comps with operating margin holding flat-to-up and continued prestige-share gains. That would confirm the 12.5% floor and the durable moat, and the de-rating becomes indefensible.

The variant view (mine): Consensus is offsides in treating a competitive tax on a still-elite franchise as a breach of the franchise. The tape (negative momentum, 6-month falling knife, 3-year dead money) and the valuation (10.8th percentile, cheapest in a decade) say the abandonment is near-complete — which is exactly when an out-of-favor quality compounder offers asymmetric value, provided the margin-floor and share-gain evidence holds. It is holding. That is the variant edge.

12. Fact vs. Interpretation Table

13. Open Questions

1. Is 12.5% the true operating-margin floor? Management guides flat-to-+20bps, but two-plus years of “stabilization” claims would need to actually print before the floor is proven. The single most important unknown.
2. What is the independent (third-party / Circana) read on ULTA’s beauty market share versus management’s “gaining prestige share” claim? (Treat the claim as hypothesis until corroborated.)
3. How dilutive is Space NK to margins and how integrated/return-accretive will international ultimately be? First acquisitive chapter; track segment disclosure.
4. What replaces the Target royalty stream, and is the net strategic effect of the exit positive (channel clarity) or negative (lost reach)?
5. Does the retail-media / UB Marketplace opportunity become financially material, and at what margin? This is the highest-value optionality and the least-disclosed.
6. Will the new management team (Steelman/DelOrefice) maintain capital-allocation discipline as the U.S. matures and the temptation to “buy growth” internationally grows — especially given an LTIP with no ROIC governor?
7. Where does the makeup category cycle go from here (38% of mix, declining)? A faddish category cooling vs. a healthy diversification into skincare/fragrance.

14. What Must Be True

For the bull case (abandoned-quality compounder, multiple too low):

• Operating margin holds at ~12.5% (or improves), confirming the normalization has bottomed.
• Comps stay positive (low-single-digit+) and ULTA continues to hold or gain prestige share against Sephora/Amazon.
• The per-share earnings engine restarts (FY2026 EPS ~$28+, +9–11%) and the buyback keeps retiring 5–7%/yr.
• International/owned-brands/retail-media are at worst neutral, at best accretive to per-share value.
• Falsification test: Two consecutive quarters of negative comparable sales with operating margin breaking below 12%, accompanied by measurable prestige-share loss. If that prints, the bear’s “structural decline” thesis is validated and the cheap multiple is a value trap, not a bargain.

For the bear case (structurally impaired, deserves a low multiple):

• The 12.5% margin is a way-station to ~10–11% as competition forces sustained promotion and SG&A reinflation.
• Comps decelerate toward flat/negative as Sephora-at-Kohl’s, Amazon, and DTC take share.
• International M&A destroys value / requires impairment; the LTIP’s lack of a return governor enables over-reach.
• EPS stalls; the multiple stays de-rated (~14x).
• Falsification test: Two-plus quarters of positive comps with operating margin flat-to-up and continued prestige-share gains. If that prints, the franchise is normalizing not declining, the de-rating to a 10.8th-percentile multiple is indefensible, and the stock re-rates.

The elegant feature of this setup: both the bull and bear falsification tests hinge on the same two observable facts — the trajectory of comps and the trajectory of operating margin — over the next two to three quarters. This is a genuine “show-me” situation with a near-term, evidence-based resolution, not a faith-based one. The balance sheet (net cash, ~$1.5B FCF, ongoing buyback) means an investor is paid to wait for the evidence.

15. Source Appendix

See the Source Appendix and Diligence Questionnaire below. Primary sources: ULTA Form 10-K (FY ended Jan-31-2026, filed Mar-26-2026) and prior 10-Ks; Form 10-Q; DEF 14A (filed Apr-22-2026); Q1 fiscal-2026 (Jun-2-2026) and Q4 fiscal-2025 (Mar-12-2026) earnings-call transcripts; ULTA earnings releases / 8-Ks. Quantitative data: ROIC.ai (statements, ratios, EV, multiples), AZI valuation percentiles and news feed, FactorsToday factor model, AZI price history. All multiples and percentiles as of June 20, 2026; price $456.13 (June 18, 2026 close).

APPENDIX A — Standard Diligence Questionnaire

APPENDIX A — Standard Diligence Questionnaire — Ulta Beauty, Inc. (NASDAQ: ULTA)

Supplemental to the research memo. Answers grounded in primary sources; Fact/Interpretation labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The central debate is binary: is the three-year operating-margin decline (16.2%→12.5%) normalization off a COVID peak, or the start of secular impairment? Sub-questions investors press: (1) Can ULTA hold prestige-beauty share against Sephora-at-Kohl’s (~900 doors) and Amazon premium beauty? (2) What is the true margin floor? (3) Is the makeup category (38% of mix, declining) cooling structurally? (4) Does the first-ever international/M&A push (Space NK, Mexico, Middle East) create or destroy value? (5) After a violent round-trip ($314→$707→$456), is the cheapest-in-a-decade multiple a bargain or a value trap? (6) Why did the Board strip the LTIP of all performance metrics?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: Off a cyclical high (FY ended Jan-2023, 16.2% op margin / high-teens comps on the post-COVID makeup boom) and now near a normalized level (12.5% margin), with management guiding margin to stabilize. EPS has plateaued ~$25–26 for three years; FY2026 is guided to re-accelerate to $28.05–28.55. So earnings are neither peak nor trough — they are normalized, with the per-share engine restarting via margin stabilization + buyback.

Driven by the external environment or internal actions? Both. External: the post-COVID beauty super-cycle (boom) and intensifying competition + consumer value-focus (the give-back). Internal: SG&A reinvestment, the “Ulta Beauty Unleashed” strategy, owned-brand and loyalty investment, and aggressive buybacks.

How stable are revenues? Very, by retail standards — beauty is a resilient, repeat-purchase, staples-like category (“lipstick effect”). Revenue grew every year except the COVID FY2021, doubling over five years. Comps decelerated to +0.7% (FY ended Jan-2025) then re-accelerated to +5.3% (Q1 FY2026).

Outlook for products/services? Healthy category growth; mix shifting from cosmetics (41%→38%) toward skincare/wellness (22%→24%) and fragrance (11%→13%) — a healthier, less faddish base.

How big will this market be? The U.S. beauty market is large (~$100B+) and structurally growing above general retail; international (UK/Mexico/Middle East) extends the addressable market but at lower returns. Primarily a U.S. story with early international optionality.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More — Sephora-at-Kohl’s, Amazon premium beauty, brand DTC, and social commerce (TikTok Shop) have all escalated. Interpretation: a permanent tax on margins, but ULTA is still gaining prestige share, so competition is intensifying without (yet) breaching the moat.

How profitable is the business (ROIC, ROE)? Elite: ROIC ~24% (down from ~34% peak but multiples of WACC), ROE ~72% (buyback-inflated), ROA ~18%, gross margin 39%, operating margin 12.5%.

How profitable is the industry — competitors, barriers? Beauty retail is attractive (vendor co-op funding, premiumization, high-30s/low-40s gross margins) but has “few barriers to entry” at the storefront level (10-K). The barrier is at the scale-and-data level (national network + 47M-member loyalty), not the individual store.

Can the business be easily understood? Yes — a specialty beauty retailer. Transparent model, clean accounting, immaterial SBC.

Undermined by foreign low-cost labor? No — domestic bricks-and-mortar + e-commerce retail/services; not labor-arbitrage-exposed.

Do brands matter? Critically. ULTA’s value is aggregating 600+ brands (mass to prestige) plus exclusive “Only at Ulta” brands and a private label — brand assortment breadth is the moat. Individual brands matter to consumers; ULTA’s edge is carrying them all.

Nature of competition? Multi-front: specialty (Sephora), mass (Target/Walmart), e-commerce (Amazon), DTC/social, and drugstores. ULTA competes on the unique mass+prestige+services format and loyalty scale.

Customers’ switching costs? Low-to-moderate. Loyalty points and habit create mild friction, but beauty shoppers are promiscuous (shop Ulta and Sephora and Amazon). The moat is scale/data, not captivity.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The ~47M-member loyalty database and brand/format intangible are not capitalized — real economic assets understating book value. Conversely, ~$655M of goodwill/intangibles from Space NK is new and carries impairment risk.

Off-balance-sheet liabilities? None material; operating leases are on the balance sheet (~$2.1B capitalized lease liabilities — the entirety of reported “debt”).

How conservative is the accounting? Conservative/clean — OCF/NI 1.30x, immaterial SBC (<0.3% of sales), lower inventory shrink, no aggressive revenue recognition. GAAP EPS ≈ economic EPS.

How CapEx-hungry? Moderate — ~$450M/yr (~3.6% of sales) for 50–60 new stores, remodels, supply chain, technology. Fully internally funded; FCF conversion is high.

Capital Allocation & Management

How much FCF, and how is it used? ~$1.5B/yr FCF. Used overwhelmingly for buybacks (no dividend) — ~$5.4B over five years, retiring ~22% of shares; target raised $1B→$1.5B for FY2026. Plus internally-funded capex and, newly, ~$387M for Space NK.

Significant acquisitions recently? Yes, the first in its history: Space NK (UK luxury beauty, ~$387M, Jul-2025), plus a Mexico JV and Middle East franchise. A strategic pivot to international; Interpretation: lower-return, unproven, integration risk.

Buying back shares? Aggressively and reasonably well-timed (much executed in the $300s–$400s); leaning in harder as the stock fell.

Issuing shares to insiders? Minimal — SBC <0.3% of sales; share count falling.

Compensation policy / incentives? Fact / demerit: annual bonus tied to “Incentive EBT” (no ROIC governor); the Board discontinued performance-based share awards, moving the LTIP to time-based RSUs/options with 3-year cliff vesting — i.e., no performance metrics in the LTIP at all. A governance soft spot, more concerning now that M&A has begun, though actual behavior has been disciplined.

Motivations of management? New CEO Kecia Steelman (Jan-2025, ex-COO) and CFO Chris DelOrefice (Oct-2025). Early scorecard strong (comp re-acceleration, margin stabilization, increased buyback). The lack of return-linked LTIP means alignment rests on share-price and ownership rather than capital-efficiency metrics.

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — a standard U.S. C-corp common stock (NASDAQ: ULTA). Ordinary 1099 treatment.

Dividend policy? No dividend; 100% of capital return via buyback.

How profitable? Among the most profitable retailers in America (24% ROIC, 39% GM, 12.5% op margin, ~9% net margin).

Net income diverging from cash from operations? No — OCF exceeds net income (1.30x). High-quality earnings.

Risks & Downside

What would cause the stock to decline? Negative comps; operating margin breaking below 12%; measurable prestige-share loss to Sephora/Amazon; a consumer recession; an international M&A misstep/impairment; or simply continued multiple de-rating on “ex-growth retailer” fears.

Risk of a catastrophic loss? Very low — net cash, no funded debt, ~$1.5B FCF, durable profitable franchise. No leverage or liquidity risk.

Chance of a total loss? Negligible. The risk is under-performance/value-trap, not impairment of capital.

Recent News & Events

Has the business environment changed recently? Yes: (1) intensifying competition (Sephora-at-Kohl’s, Amazon); (2) the Ulta-Beauty-at-Target partnership ending Aug-2026 (mutual non-renewal); (3) first international/M&A push (Space NK Jul-2025, Mexico Aug-2025, Middle East Nov-2025); (4) new CEO/CFO; (5) launch of TikTok Shop, UB Marketplace, Klarna BNPL, Uber Eats same-day. Q1 FY2026 (Jun-3-2026): sales +11.1%, comps +5.3%, EPS $7.74 (+15.5%), buyback target raised — but the stock fell on a “muted” full-year guide implying H2 deceleration.

Significant acquisitions? Space NK (see above) — the most material strategic change in company history.

Change in accounting policies? None material.

Recent changes — new markets, facilities, management? International market entries (UK/Mexico/Middle East); new CEO/CFO; continued 50–60 net new U.S. stores/year; new digital channels (TikTok Shop, marketplace).

APPENDIX B — Source Appendix

APPENDIX B — Source Appendix — Ulta Beauty, Inc. (NASDAQ: ULTA)

All figures as of June 20, 2026 unless noted. Price $456.13 (June 18, 2026 close). Primary sources prioritized; third-party aggregated data reconciled to filings.

Primary — SEC Filings (EDGAR, CIK 0001403568)

Primary — Earnings Call Transcripts

Quantitative Data Sources (public / third-party; reconciled to filings)

Key Quantitative Facts (reconciled)

• Price/valuation (6/18/26): $456.13; ~17.8x trailing P/E (TTM EPS $25.56); ~16x FY2026 forward; ~12x EV/EBITDA; ~1.66x P/S; ~7.3x P/B; ~8% FCF yield; AZI composite 10.8th percentile.
• Revenue (FY ending Jan): $6.15B (2021) → $8.63B → $10.21B → $11.21B → $11.30B → $12.39B (2026).
• Operating margin: 5.95% (2021) → 15.1% → 16.2% (2023 peak) → 15.0% → 14.0% → 12.5% (2026).
• Diluted EPS: $3.11 (2021) → $17.98 → $24.01 → $26.03 → $25.34 → $25.64 (2026).
• ROIC ~24%; ROE ~72%; gross margin 39.1%.
• FCF FY ended Jan-2026 ~$1.50B; OCF/NI 1.30x; SBC ~$37M.
• Balance sheet: net cash; cash+ST inv $494M; “debt” $2.1B = capitalized operating leases only.
• Buybacks: ~$5.4B over 5 yrs; shares 56.6M → 44.2M (−22%); FY2026 target $1.5B. No dividend.
• Stores: 1,591 (1,505 US + 86 intl, incl. 86 Space NK UK/Ireland) as of Jan-31-2026; ~47M loyalty members.
• Category mix (FY ended Jan-2026): Cosmetics 38%, Skincare & wellness 24%, Haircare 19%, Fragrance 13%, Services 4%, Other 2%.
• FY2026 guidance: sales +6–7% ($13.1–13.2B); comps +2.5–3.5%; op margin flat-to-+20bps; diluted EPS $28.05–28.55; 50–60 net new stores.

Notable Public Events (for price-action map)

• Mar-2024: management flags beauty “softening” + rising competition; stock −15%; Q1 guide cut → trend toward $320 low (Aug-2024).
• Aug-2024: Berkshire Hathaway 13F discloses a ULTA stake (Q2-2024); Berkshire largely exits by Q3-2024 (per subsequent 13F).
• Jan-2025: CEO transition — Kecia Steelman succeeds Dave Kimbell.
• Mar-13-2025: $314.47 cycle low (weak fiscal-2025 guide).
• Feb-17-2026: $706.82 all-time high.
• Mar-13-2026: −14% on Q4 FY2025 print + FY2026 guide.
• Jun-2026: grind to 52-week low (~$451) post Q1; TD Cowen PT cut to $600 (still above price).

Management commentary (share gains, guidance) is treated as hypothesis and labeled where used; independent third-party share data (e.g., Circana) was not separately obtained and is flagged as an open question.